Board members Arne Reinemo and Inger Rydin have today informed Biotec Pharmacon
ASA and the Board that they resign from the Board with immediate effect.
As the remaining Board does not comply with the requirements regarding board
composition, the Board will as soon as practically possible call for an
extraordinary general meeting.
The Board wishes to thank Arne and Inger for their contribution to the board
over the last few years.
The Board is aware that investors await a company update and will get back to
the market as soon as possible.
For further information, please contact
Chairman of the Board, Dr. Marie Roskrow, Mobile: + 44(0) 7496 959743